Atlas Arteria (M82) Q2 2026 Earnings Report

The call presented a mixed picture. Operationally the portfolio showed resilience — underlying NPAT rose 29%, constant-currency revenue and EBITDA were marginally positive, Dulles and Chicago traffic grew, APRR issued EUR 500m of bonds, and the company maintained its $0.40 distribution guidance while strengthening liquidity. Offsetting this were sizable one-off non-operating charges (put option accounting and settlement, takeover and change-of-control costs), adverse FX translating to a ~3.9% revenue and ~3.6% EBITDA decline in AUD terms, a TRIP bond downgrade, and governance/ownership uncertainty following IFM increasing its stake to ~67%. Overall the operational positives are meaningful but balanced by significant near-term headwinds and one-off costs, leaving the tone cautiously neutral.

Management reaffirmed 2026 distribution guidance of $0.40 per security (with $0.20 to be paid in October) but said it will not provide a quantified distribution target beyond the 1‑year period, instead reverting to its distribution policy of paying 90–110% of free cash flow (while noting 2026 is expected to be above that range due to the French temporary supplemental tax and one‑offs). Key metrics cited: operating free cash flow per security was $0.191 (down 1.5% vs H1 2025); underlying NPAT was $94.3m (up 29%); on a constant‑currency basis proportional toll revenue was up 0.6% and proportional EBITDA up 0.9% (FX weakened results, leaving proportional toll revenue and EBITDA down 3.9% and 3.6% respectively); cash received from businesses was A$296m (1% lower YoY) with A$5.8m net proceeds from the FX hedge program; pro‑forma corporate cash was A$100m; APRR priced €500m of bonds in January; a new US$150m three‑year corporate facility was established to fund the US$100m put‑option settlement (the put produced an $89.1m fair‑value movement and $37.5m settlement expense), and material non‑operating charges included $24.1m of IFM takeover costs and $16.9m of change‑of‑control employee costs.